Drug companies are having a harder time when it comes to getting their painkillers to succeed in clinical trials.”But this isn’t necessarily because the drugs are getting worse. An extensive analysis of trial data has found that responses to sham treatments have become stronger over time, making it harder to prove a drug’s advantage over placebo.” And it seems to be a uniquely American issue. (It’s a lot easier to kick an addiction to the placebos.)